Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 97,473	$ 79,506
Marketable securities	326,681	446,729
Trade accounts receivable, net of allowance for credit losses of $25,226 and $41,205	51,132	52,749
Other current assets	32,559	48,889
Total current assets	507,845	627,873
Marketable securities, long-term	423,571	326,648
Redeemable preferred stock investment	20,438	12,385
Fixed assets, net	83,464	81,353
Intangible assets, net	143,053	150,643
Goodwill, net	22,055	143,027
Other long-term assets	34,902	44,124
Total assets	1,235,328	1,386,053
Current liabilities
Accounts payable	15,360	23,093
Accrued liabilities	30,737	24,981
Contract liabilities	2,874	3,199
Customer deposit	22,700	10,895
Investment margin loan		14,999
Notes payable, current portion	1,183	5,639
Other current liabilities	164	5,301
Total current liabilities	73,018	88,107
Unrecognized tax benefits	5,978	9,836
Deferred tax liabilities	7,962
Other long-term liabilities	15,084	18,235
Total liabilities	102,042	116,178
Commitments and contingencies (Note 8)
Stockholders’ equity
Common stock, $0.0001 par value per share, 50,000 shares authorized, 32,416 shares issued and 29,653 shares outstanding and 31,248 shares issued and 29,438 shares outstanding	3	3
Preferred stock, $0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding
Additional paid-in capital	501,718	486,585
Accumulated other comprehensive income (loss)	1,205	(20,903)
Retained earnings	633,175	801,000
Total Fulgent stockholders' equity	1,136,101	1,266,685
Noncontrolling interest	(2,815)	3,190
Total stockholders’ equity	1,133,286	1,269,875
Total liabilities and stockholders’ equity	$ 1,235,328	$ 1,386,053